Phase II Trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy

被引：1

作者：

Wenham, R. ^{[1
]}

LaPolla, J. ^{[2
]}

Hui-Yi, L. ^{[1
]}

Apte, S. ^{[1
]}

Roberts, W. ^{[1
]}

Lancaster, J. ^{[1
]}

Bosquet, J. Gonzalez ^{[1
]}

Theodore, S. ^{[1
]}

Havrilesky, L. ^{[3
]}

Alvarez-Secord, A. ^{[3
]}

机构：

[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA

[2] Womens Canc Associates, St Petersburg, FL USA

[3] Duke Univ, Med Ctr, Durham, NC USA

来源：

GYNECOLOGIC ONCOLOGY | 2011年 / 121卷 / 01期

关键词：

D O I：

10.1016/j.ygyno.2010.12.199

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

192

引用

页码：S83 / S84

页数：2

共 50 条

[21] Final results of a phase I trial of fasting prior to platinum-based chemotherapy. [J].

Quinn, David I. ;

Groshen, Susan G. ;

Shah, Manali ;

Tsao-Wei, Denice D. ;

Garcia, Agustin A. ;

Huyen Pham ;

Lin, Yvonne Gail ;

Ketchens, Charlean ;

Massopust, Kristy ;

Wei, Min ;

Longo, Valter ;

Dorff, Tanya B. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)

[22] Effects of PARP Inhibitors on Subsequent Platinum-Based Chemotherapy in Patients with Recurrent Ovarian Cancer [J].

Kokabu, Tetsuya ;

Tarumi, Yosuke ;

Aoki, Kota ;

Okamura, Ayaka ;

Aoyama, Kohei ;

Kataoka, Hisashi ;

Yoriki, Kaori ;

Mori, Taisuke .

CANCERS, 2024, 16 (15)

[23] A phase II trial on the combination of bevacizumab and irinotecan in recurrent ovarian cancer. [J].

Ling, Huichung Tina ;

Muggia, Franco ;

Speyer, James L. ;

Curtin, John Patrick ;

Blank, Stephanie V. ;

Boyd, Leslie R. ;

Pothuri, Bhavana ;

Li, Xiaochun ;

Goldberg, Judith D. ;

Tiersten, Amy .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[24] Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer [J].

Anwer, Khursheed ;

Kelly, F. Joseph ;

Chu, Christina ;

Fewell, Jason G. ;

Lewis, Danny ;

Alvarez, Ronald D. .

GYNECOLOGIC ONCOLOGY, 2013, 131 (01) :169-173

[25] Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy [J].

Leu, KM ;

Kim, KM ;

Larson, M ;

Schiller, JH .

LUNG CANCER, 2001, 34 (01) :105-113

[26] Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer [J].

Markman, Maurie .

GYNECOLOGIC ONCOLOGY, 2007, 106 (01) :273-274

[27] Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial (vol 21, pg 699, 2020) [J].

Pfisterer, J. ;

Shannon, C. M. ;

Baumann, K. .

LANCET ONCOLOGY, 2022, 23 (06) :E248-E248

[28] Final results of a phase II trial of prolgolimab with platinum-based therapy and bevacizumab in patients with advanced cervical cancer [J].

Fogt, Sergey ;

Andabekov, Timur ;

Shamsutdinova, Yana ;

Dvorkin, Mikhail ;

Artamonova, Elena ;

Chistyakov, Valerii ;

Zukov, Ruslan ;

Moiseenko, Vladimir ;

Nechaeva, Marina ;

Odintsova, Svetlana ;

Fadeeva, Natalia ;

Kislov, Nikolai ;

Tantsyrev, Denis ;

Tjulandin, Sergei ;

Fomin, Eugeniy ;

Linkova, Iuliia ;

Zinkina-Orikhan, Arina ;

Shustova, Mariia ;

Zhukova, Lyudmila .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

[29] Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab plus chemotherapy for platinum-resistant recurrent ovarian cancer [J].

Husain, Amreen ;

Wang, Yan ;

Hanker, Lars C. ;

Ojeda, Belen ;

Anttila, Maarit ;

Breda, Enrico ;

Vuylsteke, Peter ;

Pujade-Lauraine, Eric .

GYNECOLOGIC ONCOLOGY, 2016, 142 (03) :465-470

[30] Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial [J].

Bamias, A. ;

Gibbs, E. ;

Lee, C. Khoon ;

Davies, L. ;

Dimopoulos, M. ;

Zagouri, F. ;

Veillard, A. -S. ;

Kosse, J. ;

Santaballa, A. ;

Mirza, M. R. ;

Tabaro, G. ;

Vergote, I. ;

Bloemendal, H. ;

Lykka, M. ;

Floquet, A. ;

Gebski, V. ;

Pujade-Lauraine, E. .

ANNALS OF ONCOLOGY, 2017, 28 (08) :1842-1848

← 1 2 3 4 5 →